U
UltraSight
Health Tech & Medtech · Rehovot, Israel · Founded 2018
Real-time guidance and quality assessment to allow healthcare professionals to consistently perform high-quality cardiac ultrasound in a variety of settings MoreLess
UltraSight is a pioneering company in the medical technology sector, focusing on revolutionizing cardiac ultrasound through advanced machine learning. The company's core product is an AI-guided ultrasound system that aids healthcare professionals in making more accurate and timely clinical decisions. UltraSight's technology is designed to be used in various care settings, from doctors' offices and community hospitals to ambulances and remote communities, thereby increasing patient access to high-quality cardiac imaging. The business primarily serves healthcare providers, including hospitals, clinics, and emergency medical services, operating within the global healthcare market. UltraSight's business model involves selling its AI-guided ultrasound systems and software subscriptions to medical institutions. The company generates revenue through direct sales, partnerships, and collaborations with major healthcare providers and technology companies, such as GE Healthcare. By leveraging machine learning and AI, UltraSight aims to democratize access to advanced cardiac care, making it more widely available and improving patient outcomes.
Keywords: AI-guided ultrasound, cardiac imaging, machine learning, healthcare technology, point-of-care, clinical decisions, medical devices, remote diagnostics, healthcare access, advanced imaging.
Company overview
UltraSight company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2018
- Headquarters
- Rehovot, Israel
- Employees
- 42
- Open positions
- None listed
- Dealroom signal
- 76.8
Valuation & funding
UltraSight funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jun 2023 | $0 | — | SELVAS Healthcare (Formerly Hana Must Second Special Purpose Acquisition Company) | ↗ |
| SPINOUT✓Other financing | Aug 2022 | $0 | — | Weizmann Institute of Science | ↗ |
| SERIES B✓Equity / VC | May 2021 | $13M | $52M | Yozma Group · Atain specialty insurance company · Weizmann Institute of Science | — |
| SERIES AEquity / VC | Mar 2019 | $2M | $8M | Yozma Group | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $2.9M | 0% | 42 |
| 2025 | $2.9M | 0% | 39 |
| 2024 | $2.9M | 0% | 34 |
| 2023 | $2.9M | +26.1% | 29 |
| 2022 | $2.3M | +135.9% | 26 |
| 2021 | $975K | — | 13 |
Growth signals
UltraSight website traffic
Latest recorded traffic for UltraSight is 1.8K monthly website visits, up 63.6% over the last three months. UltraSight's team grew 7.7% over the past year.
Comparisons
UltraSight compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
UltraSight's talent
Source: Dealroom Talent Intelligence.
Investors
4 investors on UltraSight's cap table
Sourced from Dealroom's funding and investor records.




Global footprint
Where UltraSight has talent and traffic
team presence
In the news
Latest news about UltraSight
Recent press, funding announcements, and product moves mentioning UltraSight — open to read from the original sources.
Market sentiment
What the market is saying about UltraSight
An AI-synthesized read of the highest-engagement posts about UltraSight on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See UltraSight’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







